IL17A and hyperuricemia: According to the results of KEGG enrichment analysis, the following pathways related to the treatment of gout and hyperuricemia were selected for analysis: IL-17 signaling pathway, HIF-1 signaling pathway, relaxin signaling pathway, TNF signaling pathway, and advanced glycation end products-receptor for advanced glycation end products (AGE-RAGE) signaling pathway in diabetic complications.